Standout Papers

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons 2022 2026 2023 2024270
  1. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons (2022)
    Adel Naimi, Rebar N. Mohammed et al. Cell Communication and Signaling

Immediate Impact

55 standout
Sub-graph 1 of 24

Citing Papers

Electrospun fiber‐based immune engineering in regenerative medicine
2024 Standout
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
2024 Standout
1 intermediate paper

Works of Adel Naimi being referenced

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
2022 Standout
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
2021

Author Peers

Author Last Decade Papers Cites
Adel Naimi 212 271 186 14 591
Matthias Piesche 218 384 316 17 674
Rhiannon Morris 251 260 255 11 722
Yulia Liubomirski 221 266 208 11 665
Rahul R. Deshmukh 225 309 175 12 553
Erin E. Childs 242 189 240 12 637
M.A. Gross 156 138 305 21 682
Jiankun Zhu 202 182 408 16 695
Masafumi Shibamori 259 185 255 15 668
Maxine S. Emmett 224 284 105 14 624
Martha Gschwandtner 197 157 278 13 664

All Works

Loading papers...

Rankless by CCL
2026